Actively Recruiting
Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)
Led by AstraZeneca · Updated on 2026-05-07
5000
Participants Needed
37
Research Sites
159 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is an observational multicenter cross-sectional study. Planned study population consists of 5 000 adult patients with uncontrolled SA receiving treatment according to standard of care (except biologics). Planned number of study site is 50 outpatient centers with experience of uncontrolled SA treatment in about 50 regions of Russia (in order to describe characteristics of patients with uncontrolled SA in different regions in the most comprehensive way). This non-interventional study does not imply any intervention into a routine clinical practice, and does not provide for any diagnostic and therapeutic procedures other than those used in routine practice.
CONDITIONS
Official Title
Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older at the time of inclusion
- Signed informed consent according to ICH GCP and local law
- Diagnosis of uncontrolled severe asthma established at least 52 weeks before inclusion, with ACQ-5 score greater than 1.5
- Severe asthma treated for at least 3 months before inclusion with medium or high doses of inhaled corticosteroids plus LABA and/or ALP and/or LAMA and/or systemic corticosteroids and/or immunobiological therapy, where attempts to reduce therapy lead to loss of control or asthma remains uncontrolled
- Availability of at least 52 weeks of follow-up data prior to inclusion in medical records
You will not qualify if you...
- Current or recent (within 52 weeks) use of any biological therapy
- Presence or history of chronic obstructive pulmonary disease (COPD) or idiopathic pulmonary fibrosis (ILF)
- Participation in any clinical study currently or within 52 weeks prior to inclusion
- Any acute or chronic disease that limits ability to participate or could affect interpretation of results as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 37 locations
1
Research Site
Astrakhan, Russia
Actively Recruiting
2
Research Site
Barnaul, Russia
Actively Recruiting
3
Research Site
Blagoveshchensk, Russia
Actively Recruiting
4
Research Site
Bryansk, Russia
Actively Recruiting
5
Research Site
Chelyabinsk, Russia
Actively Recruiting
6
Research Site
Gatchina, Russia
Actively Recruiting
7
Research Site
Irkutsk, Russia
Actively Recruiting
8
Research Site
Izhevsk, Russia
Actively Recruiting
9
Research Site
Kazan', Russia
Actively Recruiting
10
Research Site
Kemerovo, Russia
Actively Recruiting
11
Research Site
Khabarovsk, Russia
Actively Recruiting
12
Research Site
Krasnodar, Russia
Actively Recruiting
13
Research Site
Krasnoyarsk, Russia
Actively Recruiting
14
Research Site
Moscow, Russia
Actively Recruiting
15
Research Site
Murmansk, Russia
Actively Recruiting
16
Research Site
Nal'chik, Russia
Actively Recruiting
17
Research Site
Nizhny Novgorod, Russia
Actively Recruiting
18
Research Site
Novosibirsk, Russia
Actively Recruiting
19
Research Site
Omsk, Russia
Actively Recruiting
20
Research Site
Orenburg, Russia
Actively Recruiting
21
Research Site
Petrozavodsk, Russia
Actively Recruiting
22
Research Site
Rostov-on-Don, Russia
Actively Recruiting
23
Research Site
Ryazan, Russia
Actively Recruiting
24
Research Site
Saint Petersburg, Russia
Actively Recruiting
25
Research Site
Samara, Russia
Actively Recruiting
26
Research Site
Saratov, Russia
Actively Recruiting
27
Research Site
Stavropol, Russia
Actively Recruiting
28
Research Site
Tomsk, Russia
Actively Recruiting
29
Research Site
Ufa, Russia
Actively Recruiting
30
Research Site
Ulan-Ude, Russia
Actively Recruiting
31
Research Site
Verkhnyaya Pyshma, Russia
Actively Recruiting
32
Research Site
Vladimir, Russia
Actively Recruiting
33
Research Site
Vladivostok, Russia
Actively Recruiting
34
Research Site
Volgograd, Russia
Actively Recruiting
35
Research Site
Voronezh, Russia
Actively Recruiting
36
Research Site
Yakutsk, Russia
Actively Recruiting
37
Research Site
Yekaterinburg, Russia
Actively Recruiting
Research Team
A
AstraZeneca Clinical Study Information Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here